Table 1 Treatment groups

Mock

Normal saline (NS) was administered as control

shScr-V

VNP20009 carrying the scrambled shRNA construct was administered

shSox2-V

VNP20009 carrying the Sox2 shRNA construct was administered

HM-3

HM-3 was administered

HM-3 + shScr-V

Both HM-3 and shScr-V were administered

HM-3 + shSox2-V

Both HM-3 and shSox2-V were administered

Docetaxel

Docetaxel was administered